FluroTech (TSXV:TEST), (“FluroTech” or the “Company”) is pleased to announce that it has finalized the engineering & design of its flagship product, CompleTest™, and engaged a third party manufacturer to produce the first commercial production run of the housing for the CompleTest™ Series 1 device.

The desktop device will commence commercial production July 2018 and is expected to be available for sale in Canada by October 2018, along with the first of a series of test kits that will be made available sequentially to the Cannabis industry over the next year and a half. Sales to international markets are expected in the first half of 2019.


“Over a decade of research has gone into the development of the CompleTest™ devices and test kits,” stated Dr. Elmar Prenner, Chief Technology Officer. “We believe this disruptive technology is a step change when compared to conventional high-performance liquid chromatography and mass spectroscopy, which require trained lab technicians to perform experiments and interpret complex sets of data.” Dr. Prenner explained that because the CompleTest™ allows users to obtain highly accurate results within minutes rather than waiting days or weeks for results from third party labs, it may allow cannabis producing companies to move from a compliance mindset to optimizing production by providing them tools to produce the highest quality products for their consumers.

Cross lab variability and a desire to understand one’s product before sending it for third party certification has led Canadian licensed producers and international growers to express a keen interest to be able to carry out in-house quality control and THC/CBD potency optimization.

“Opportunities for effective cannabis testing technology continue to expand with the recent legalization of recreational cannabis in Canada,” explained Danny Dalla-Longa, Chief Executive Officer. “CompleTest™ will fill a gap in the testing market, enabling growers, retailers and regulators to employ a user friendly, in-house option to affordably test cannabis, resulting in fast, accurate and repeatable results.”

About CompleTest

CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of- the-art cannabis testing device, able to provide quick, accurate and consistent testing results. It’s designed for cultivators, dispensaries and anyone with a vested interest in consumer safety to test the quality and safety of their cannabis products and to optimize potency yield.

About FluroTech (TSXV: TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com and watch our video.

Contact Information
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com

Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com

Prit Singh
IR — Thesis Capital Inc.
905.510.7636
psingh@thesiscapital.ca

Click here to connect with FluroTech (TSXV:TEST) for an Investor Presentation.

Source: www.newsfilecorp.com

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less